Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)

NCT02725476 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

IgG4-RD

Interventions

BIOLOGICAL: XmAb5871

Sponsor

Xencor, Inc.

Collaborators

[object Object]